Neeraj Chadawar of Axis Securities believes that market volatility is likely to provide good opportunities for Midcaps and Small caps.
IT and pharma are preferred themes by experts after June quarter earnings
Given that India will remain a growth market in the long-term one cannot neglect growth stocks for a prolonged period of time, Jyoti Roy advised.
Experts and analysts expect a change in market leadership in the post-COVID world in which telecom, healthcare, speciality chemicals, and rural consumers may dominate other sectors.
This war between USA & China may intensify further & may take ugly shape going forward, which may change World Power Equation post-COVID-19 era, Amit Jain of Ashika Wealth Advisors said.
Nifty on March 4 slid almost 200 points during the day but witnessed a sharp recovery in the second half of the session.
Vineeta Sharma of Narnolia Financial Advisors also feels results declared so far have been slightly below their estimate.
The apt strategy to trade in such a market would be to play the range i.e. buy as close as possible to support and vice versa.
Analysts feel investors will still focus on quality stocks only in 2020
The rupee's fall is technical in nature and should be viewed in accordance with happenings across the globe.
Mitessh Thakkar of miteshthacker.com recommends buying HDFC Bank, Lupin, Larsen & Toubro and Delta Corp.
Sandeep Wagle of powermywealth.com is of the view that one may hold Alembic Pharmaceuticals.
Mitessh Thakkar of miteshthacker.com recommends buying Equitas Holdings, Jet Airways, South Indian Bank, ABB India and Alembic Pharmaceuticals.
Mitessh Thakkar of miteshthacker.com suggests selling Adani Enterprises, BEML and Syndicate Bank and advises buying UltraTech Cement and Alembic Pharmaceuticals.
In an interview to CNBC-TV18, Ajay Bodke, CEO & Chief Portfolio Manager (PMS) at Prabhudas Lilladher Pvt. Ltd shared his readings and outlook on market, specific stocks and sectors.
SP Tulsian, sptulsian.com in an interview to CNBC-TV18 shared his views on stocks like Dish TV, Alembic pharma, sugar stocks, SPARC, Sundaram Finance and others
Mehraboon Irani of Nirmal Bang Securities is of the view that one may prefer Glenmark Pharma, Alembic Pharma and Alkem Laboratories.
Alembic Pharma is a vertically integrated pharmaceutical company with major focus on formulations business in India and US.
CLSA has a sell rating on Tata Steel with a target of Rs 235 per share. It remains negative given weak steel price environment.
SP Tulsian, sptulsian.com in an interview to CNBC-TV18 while sharing his views why 8K Miles does not warrant a buy at current levels and why he is bullish on the pharma space.
Sameet Chavan of Angel Broking suggests buying Apollo Tyres with a target of Rs 157.
In an interview to CNBC-TV18, Daljeet Singh Kohli of India Nivesh Securites shared his readings and outlook on specific stocks and sector.
Mehraboon Irani of Nirmal Bang Securities is of the view that one can buy Sun Pharma at around Rs 750.
Mehraboon Irani of Nirmal Bang Securities is of the view that Glenmark Pharma and Alembic Pharmaceuticals are the best picks from the pharma space.